On the public citation graph

Red Blood Cell Membrane Processing for Biomedical Applications

https://doi.org/10.3389/fphys.2019.01070

0 signed · 114 inferred · view as graph

Inferred edges come from two machine sources: sweeps of open repository metadata (mostly SSRN and Zenodo), and a bulk OpenAlex citation snapshot. Every row below is labelled with the one it came from. Neither is a complete citation index — absence here is not evidence of absence.

Is this your work? Sign in with ORCID and put your name on the claims that are yours.

Claim with ORCID

Reference health. See whether every reference in this work resolves to a known work and none has been retracted — and get a dated CiteStamped badge you can embed.

See reference health

What this work says

Outgoing claims: the papers this work cites, builds on, or argues with.

inferredcites →https://doi.org/10.1002/ajh.24093openalex-snapshot

A P hase 2 study of L ‐asparaginase encapsulated in erythrocytes in elderly patients with P hiladelphia chromosome negative acute lymphoblastic leukemia: The GRASPALL/GRAALL‐SA 2‐2008 study

inferredcites →https://doi.org/10.1002/wnan.1454openalex-snapshot

Reengineering red blood cells for cellular therapeutics and diagnostics

inferredcites →https://doi.org/10.1006/abio.1993.1057openalex-snapshot

Tannin-Mediated Attachment of Avidin Provides Complement-Resistant Immunoerythrocytes That Can Be Lysed in the Presence of Activator of Complement

inferredcites →https://doi.org/10.1006/abio.1996.0384openalex-snapshot

Regulation of the Complement-Mediated Elimination of Red Blood Cells Modified with Biotin and Streptavidin

inferredcites →https://doi.org/10.1007/978-1-4615-3030-5openalex-snapshot

The Use of Resealed Erythrocytes as Carriers and Bioreactors

inferredcites →https://doi.org/10.1007/978-1-4615-3030-5_23openalex-snapshot

Comparison of Uricase-Bound and Uricase-Loaded Erythrocytes as Bioreactors for Uric Acid Degradation

inferredcites →https://doi.org/10.1007/bf00926740openalex-snapshot

Modulated red blood cell survival by membrane protein clustering

inferredcites →https://doi.org/10.1007/s10545-016-9926-0openalex-snapshot

Erythrocyte‐mediated delivery of recombinant enzymes

inferredcites →https://doi.org/10.1016/0005-2736(90)90047-ropenalex-snapshot

Electroinsertion of full length recombinant CD4 into red blood cell membrane

inferredcites →https://doi.org/10.1016/0005-2736(91)90254-6openalex-snapshot

Electroinsertion of xeno proteins in red blood cell membranes yields a long lived protein carrier in circulation

inferredcites →https://doi.org/10.1016/0014-5793(83)80160-4openalex-snapshot

Red blood cell targeting to collagen‐coated surfaces

inferredcites →https://doi.org/10.1016/0076-6879(87)49062-9openalex-snapshot

[24] Large-scale entrapment of drugs into resealed red blood cells using a continuous-flow dialysis system

inferredcites →https://doi.org/10.1016/j.addr.2007.08.029openalex-snapshot

Cell-based drug delivery

inferredcites →https://doi.org/10.1016/j.addr.2016.02.007openalex-snapshot

Red blood cells: Supercarriers for drugs, biologicals, and nanoparticles and inspiration for advanced delivery systems

inferredcites →https://doi.org/10.1016/j.addr.2016.05.008openalex-snapshot

Engineering erythrocytes for the modulation of drugs' and contrasting agents' pharmacokinetics and biodistribution

inferredcites →https://doi.org/10.1016/j.addr.2017.06.007openalex-snapshot

Bioengineering strategies for inducing tolerance in autoimmune diabetes

inferredcites →https://doi.org/10.1016/j.ijpharm.2012.12.044openalex-snapshot

Red blood cells as innovative antigen carrier to induce specific immune tolerance

inferredcites →https://doi.org/10.1016/j.ijpharm.2016.12.011openalex-snapshot

Ex vivo encapsulation of dexamethasone sodium phosphate into human autologous erythrocytes using fully automated biomedical equipment

inferredcites →https://doi.org/10.1016/j.molimm.2003.10.017openalex-snapshot

ScFv-mediated in vivo targeting of DAF to erythrocytes inhibits lysis by complement

inferredcites →https://doi.org/10.1016/j.vaccine.2006.05.013openalex-snapshot

The mouse immune response to carrier erythrocyte entrapped antigens

inferredcites →https://doi.org/10.1016/s0014-5793(00)01204-7openalex-snapshot

Preparation and characterization of ‘heparinocytes’: erythrocytes with covalently bound low molecular weight heparin

inferredcites →https://doi.org/10.1016/s0264-410x(02)00746-6openalex-snapshot

Red blood cell-mediated delivery of recombinant HIV-1 Tat protein in mice induces anti-Tat neutralizing antibodies and CTL

inferredcites →https://doi.org/10.1016/s0264-410x(96)00181-8openalex-snapshot

Red blood cells as delivery system for recombinant HSV-1 glycoprotein B: immunogenicity and protection in mice

inferredcites →https://doi.org/10.1021/nn404853zopenalex-snapshot

Delivering Nanoparticles to Lungs while Avoiding Liver and Spleen through Adsorption on Red Blood Cells

inferredcites →https://doi.org/10.1034/j.1600-065x.2001.1800109.xopenalex-snapshot

CR1 and CR1‐like: the primate immune adherence receptors

inferredcites →https://doi.org/10.1038/s41467-017-00448-0openalex-snapshot

Genetically engineered red cells expressing single domain camelid antibodies confer long-term protection against botulinum neurotoxin

inferredcites →https://doi.org/10.1038/s41467-018-05079-7openalex-snapshot

Red blood cell-hitchhiking boosts delivery of nanocarriers to chosen organs by orders of magnitude

inferredcites →https://doi.org/10.1038/srep15907openalex-snapshot

Memory of tolerance and induction of regulatory T cells by erythrocyte-targeted antigens

inferredcites →https://doi.org/10.1073/pnas.1216353110openalex-snapshot

Engineering antigens for in situ erythrocyte binding induces T-cell deletion

inferredcites →https://doi.org/10.1073/pnas.1409861111openalex-snapshot

Engineered red blood cells as carriers for systemic delivery of a wide array of functional probes

inferredcites →https://doi.org/10.1073/pnas.1701746114openalex-snapshot

Engineered erythrocytes covalently linked to antigenic peptides can protect against autoimmune disease

inferredcites →https://doi.org/10.1073/pnas.70.9.2663openalex-snapshot

Enzyme Loading of Erythrocytes

inferredcites →https://doi.org/10.1073/pnas.83.10.3311openalex-snapshot

Membrane phospholipid asymmetry as a determinant of erythrocyte recognition by macrophages.

inferredcites →https://doi.org/10.1073/pnas.88.10.4409openalex-snapshot

Full-length CD4 electroinserted in the erythrocyte membrane as a long-lived inhibitor of infection by human immunodeficiency virus.

inferredcites →https://doi.org/10.1073/pnas.88.8.3305openalex-snapshot

Use of heteropolymeric monoclonal antibodies to attach antigens to the C3b receptor of human erythrocytes: a potential therapeutic treatment.

inferredcites →https://doi.org/10.1073/pnas.89.14.6477openalex-snapshot

Targeting antiretroviral nucleoside analogues in phosphorylated form to macrophages: in vitro and in vivo studies.

inferredcites →https://doi.org/10.1073/pnas.93.9.4403openalex-snapshot

Synthesis and targeted delivery of an azidothymidine homodinucleotide conferring protection to macrophages against retroviral infection.

inferredcites →https://doi.org/10.1089/aid.1998.14.435openalex-snapshot

Macrophage Protection Against Human Immunodeficiency Virus or Herpes Simplex Virus by Red Blood Cell-Mediated Delivery of a Heterodinucleotide of Azidothymidine and Acyclovir

inferredcites →https://doi.org/10.1111/j.1470-8744.1992.tb00202.xopenalex-snapshot

In vitro targeting of erythrocytes to cytotoxic T‐cells by coupling of Thy‐1.2 monoclonal antibody

inferredcites →https://doi.org/10.1111/j.1470-8744.1992.tb00221.xopenalex-snapshot

Red blood cells as an antigen‐delivery system

inferredcites →https://doi.org/10.1111/j.1470-8744.1994.tb00321.xopenalex-snapshot

Preparation and characterization of biotinylated red blood cells

inferredcites →https://doi.org/10.1111/j.1749-6632.1986.tb46556.xopenalex-snapshot

Ion Transport and Volume Regulation in Red Blood Cells

inferredcites →https://doi.org/10.1111/trf.13497openalex-snapshot

Erythrophagocytosis by plasmacytoid dendritic cells and monocytes is enhanced during inflammation

inferredcites →https://doi.org/10.1124/jpet.109.159194openalex-snapshot

Targeting of a Mutant Plasminogen Activator to Circulating Red Blood Cells for Prophylactic Fibrinolysis

inferredcites →https://doi.org/10.1126/sciadv.1500112openalex-snapshot

Engineered binding to erythrocytes induces immunological tolerance to E. coli asparaginase

inferredcites →https://doi.org/10.1128/cdli.5.2.235-241.1998openalex-snapshot

AIDS Vaccination Studies Using an Ex Vivo Feline Immunodeficiency Virus Model: Homologous Erythrocytes as a Delivery System for Preferential Immunization with Putative Protective Antigens

inferredcites →https://doi.org/10.1159/000368995openalex-snapshot

Factors Influencing RBC Alloimmunization: Lessons Learned from Murine Models

inferredcites →https://doi.org/10.1161/circulationaha.107.750257openalex-snapshot

Cerebrovascular Thromboprophylaxis in Mice by Erythrocyte-Coupled Tissue-Type Plasminogen Activator

inferredcites →https://doi.org/10.1182/asheducation-2016.1.446openalex-snapshot

Understanding red blood cell alloimmunization triggers

inferredcites →https://doi.org/10.1182/blood-2005-11-012336openalex-snapshot

Human complement receptor type 1–directed loading of tissue plasminogen activator on circulating erythrocytes for prophylactic fibrinolysis

inferredcites →https://doi.org/10.1182/blood-2008-07-161166openalex-snapshot

Red cell membrane: past, present, and future

inferredcites →https://doi.org/10.1182/blood-2011-09-382655openalex-snapshot

Transfusion in the absence of inflammation induces antigen-specific tolerance to murine RBCs

inferredcites →https://doi.org/10.1182/blood-2011-12-398149openalex-snapshot

Targeting recombinant thrombomodulin fusion protein to red blood cells provides multifaceted thromboprophylaxis

inferredcites →https://doi.org/10.1182/blood.v78.10.2611.2611openalex-snapshot

Avidin attachment to biotinylated erythrocytes induces homologous lysis via the alternative pathway of complement

inferredcites →https://doi.org/10.1182/blood.v91.5.1784openalex-snapshot

In Vitro Incorporation of GPI-Anchored Proteins Into Human Erythrocytes and Their Fate in the Membrane

inferredcites →https://doi.org/10.1182/bloodadvances.2017011734openalex-snapshot

Biocompatible coupling of therapeutic fusion proteins to human erythrocytes

inferredcites →https://doi.org/10.1189/jlb.71.4.652openalex-snapshot

Erythrocytes deliver Tat to interferon-γ-treated human dendritic cells for efficient initiation of specific type 1 immune responses in vitro

inferredcites →https://doi.org/10.1517/17425241003610633openalex-snapshot

Drug delivery by red blood cells: vascular carriers designed by mother nature

inferredcites →https://doi.org/10.1557/mrs2010.571openalex-snapshot

Shape and Biomechanical Characteristics of Human Red Blood Cells in Health and Disease

What points at this work

Incoming claims: where this work appears in other papers’ reference lists and arguments.

inferred← citeshttps://doi.org/10.2139/ssrn.4761067openalex-extracted

Engineered TP Self-Assembling Nanodrug for Targeting and Remodeling Inflammatory Microenvironment in Arthritis

inferred← citeshttps://doi.org/10.1002/2211-5463.70005openalex-snapshot

Red blood cells could protect miRNAs from degradation or loss thanks to Argonaute 2 binding

inferred← citeshttps://doi.org/10.1002/adhm.202502358openalex-snapshot

Living Cell Materials for Advanced Biomedical Applications in Disease Diagnosis, Treatment, and Prevention

inferred← citeshttps://doi.org/10.1002/anbr.202200037openalex-snapshot

Surface Modification of Erythrocytes with Lipid Anchors: Structure–Activity Relationship for Optimal Membrane Incorporation, in vivo Retention, and Immunocompatibility

inferred← citeshttps://doi.org/10.1007/978-3-031-93425-4_7openalex-snapshot

Biomaterial-Based Cell Membrane Engineering Strategies and Their Scope in Biomedical Applications

inferred← citeshttps://doi.org/10.1007/978-981-19-8930-8_8openalex-snapshot

Cellular Drug Delivery Vehicle

inferred← citeshttps://doi.org/10.1007/s11095-022-03328-5openalex-snapshot

Red Blood Cell Inspired Strategies for Drug Delivery: Emerging Concepts and New Advances

inferred← citeshttps://doi.org/10.1007/s40259-020-00415-0openalex-snapshot

Ongoing Developments and Clinical Progress in Drug-Loaded Red Blood Cell Technologies

inferred← citeshttps://doi.org/10.1016/b978-0-12-814455-8.00016-5openalex-snapshot

Resealed erythrocytes (RBCs) and their biomedical application

inferred← citeshttps://doi.org/10.1016/j.bioadv.2025.214420openalex-snapshot

Boosted breast cancer treatment with cell membrane-coated PLGA nanocarriers: Investigating the interactions with various cell types

inferred← citeshttps://doi.org/10.1016/j.biopha.2026.119920openalex-snapshot

Red blood cell-based drug delivery systems: Construction strategies, biomedical applications, and future perspectives

inferred← citeshttps://doi.org/10.1016/j.colsurfb.2022.112895openalex-snapshot

Red blood cell membrane nanoparticles for tumor phototherapy

inferred← citeshttps://doi.org/10.1016/j.copbio.2026.103521openalex-snapshot

Engineering red cells across scales: Red Blood Cells (RBCs) and RBC-derived extracellular vesicles

inferred← citeshttps://doi.org/10.1016/j.ejphar.2021.174009openalex-snapshot

Novel engineering: Biomimicking erythrocyte as a revolutionary platform for drugs and vaccines delivery

inferred← citeshttps://doi.org/10.1016/j.humimm.2024.111084openalex-snapshot

Harnessing the potential of red blood cells in immunotherapy

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2023.123241openalex-snapshot

CD38-targeted and erythrocyte membrane camouflaged nanodrug delivery system for photothermal and chemotherapy in multiple myeloma

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.124401openalex-snapshot

Red blood cells based nanotheranostics: A smart biomimetic approach for fighting against cancer

inferred← citeshttps://doi.org/10.1016/j.ijpharm.2024.124658openalex-snapshot

Recent advances with erythrocytes as therapeutics carriers

inferred← citeshttps://doi.org/10.1016/j.jconrel.2022.05.024openalex-snapshot

Prolonged blood circulation outperforms active targeting for nanocarriers-mediated enhanced hepatocellular carcinoma therapy in vivo

inferred← citeshttps://doi.org/10.1016/j.jconrel.2024.06.042openalex-snapshot

Immunogenicity-masking delivery of uricase against hyperuricemia and gout

inferred← citeshttps://doi.org/10.1016/j.jddst.2021.102530openalex-snapshot

Cancer targeted biomimetic drug delivery system

inferred← citeshttps://doi.org/10.1016/j.jddst.2026.108983openalex-snapshot

Engineered red blood cells and RBC-inspired platforms for drug delivery, transfusion, and therapeutic translation

inferred← citeshttps://doi.org/10.1016/j.mehy.2020.109976openalex-snapshot

Deceiving SARS-CoV-2 molecular-tropism clues – A combinational contemporary strategy

inferred← citeshttps://doi.org/10.1016/j.mtbio.2023.100913openalex-snapshot

Red blood cell-derived materials for cancer therapy: Construction, distribution, and applications

inferred← citeshttps://doi.org/10.1016/j.omtm.2021.03.003openalex-snapshot

In vitro characterization of engineered red blood cells as viral traps against HIV-1 and SARS-CoV-2

inferred← citeshttps://doi.org/10.1016/j.transci.2020.102933openalex-snapshot

Update on newer approaches to prevent or treat COVID-19 infection: What we all need the most right now!!

inferred← citeshttps://doi.org/10.1021/acsbiomaterials.2c01257openalex-snapshot

TNF-R1 Cellular Nanovesicles Loaded on the Thermosensitive F-127 Hydrogel Enhance the Repair of Scalded Skin

inferred← citeshttps://doi.org/10.1021/acschembio.1c00216openalex-snapshot

Asparaginyl Ligase-Catalyzed One-Step Cell Surface Modification of Red Blood Cells

inferred← citeshttps://doi.org/10.1021/acsnano.2c00320openalex-snapshot

Brain-Targeted Codelivery of Bcl-2/Bcl-xl and Mcl-1 Inhibitors by Biomimetic Nanoparticles for Orthotopic Glioblastoma Therapy

inferred← citeshttps://doi.org/10.1021/acsnano.2c11965openalex-snapshot

Advances in Drug Delivery Systems Based on Red Blood Cells and Their Membrane-Derived Nanoparticles

inferred← citeshttps://doi.org/10.1038/s41467-026-71013-xopenalex-snapshot

In vivo metabolic tagging and targeting of circulating red blood cells

inferred← citeshttps://doi.org/10.1038/s41598-024-65623-yopenalex-snapshot

Efficient and highly reproducible production of red blood cell-derived extracellular vesicle mimetics for the loading and delivery of RNA molecules

inferred← citeshttps://doi.org/10.1080/01932691.2023.2210215openalex-snapshot

Cell membrane-cloaked bioinspired nanoparticles: a novel strategy for breast cancer therapy

inferred← citeshttps://doi.org/10.1080/10717544.2020.1831103openalex-snapshot

Cell-mediated targeting drugs delivery systems

inferred← citeshttps://doi.org/10.1080/10717544.2021.1934188openalex-snapshot

Recent advances in cell membrane-camouflaged nanoparticles for inflammation therapy

inferred← citeshttps://doi.org/10.1080/17425247.2023.2219890openalex-snapshot

Preclinical and clinical developments in enzyme-loaded red blood cells: an update

inferred← citeshttps://doi.org/10.1080/2314808x.2022.2099116openalex-snapshot

Glucosamine modulates membrane and cellular ionic homeostasis: studies on accelerated senescent and naturally aged rats

inferred← citeshttps://doi.org/10.11606/t.76.2020.tde-29092020-101056openalex-snapshot

Bionanomateriais para o cruzamento de barreira biológica e entrega controlada

inferred← citeshttps://doi.org/10.1186/s12951-026-04589-7openalex-snapshot

Cell-based drug delivery for combating bacteria: focus on refractory infections

inferred← citeshttps://doi.org/10.2174/1567201820666230320103529openalex-snapshot

Erythrocyte-based Drug Delivery: How Far from Clinical Application?

inferred← citeshttps://doi.org/10.26434/chemrxiv.11894904openalex-snapshot

Triptolide Self-Assembling Nanoparticles Engineering with Modified Erythrocyte Membranes for Targeting and Remodeling Inflammatory Microenvironment in Arthritis

inferred← citeshttps://doi.org/10.26434/chemrxiv.11894904.v1openalex-snapshot

T cell/Macrophage Dual-Targeting Biomimetic Triptolide Self-Assembly Nanodrugs For Rheumatoid Arthritis Therapy by Inflammatory Microenvironment Remodeling

inferred← citeshttps://doi.org/10.26434/chemrxiv.11894904.v2openalex-snapshot

Triptolide Self-Assembling Nanoparticles Engineering with Modified Erythrocyte Membranes for Targeting and Remodeling Inflammatory Microenvironment in Arthritis

inferred← citeshttps://doi.org/10.3389/fchem.2020.00703openalex-snapshot

Membrane Active Peptides Remove Surface Adsorbed Protein Corona From Extracellular Vesicles of Red Blood Cells

inferred← citeshttps://doi.org/10.3389/fimmu.2022.1015585openalex-snapshot

Engineered red blood cells (activating antigen carriers) drive potent T cell responses and tumor regression in mice

inferred← citeshttps://doi.org/10.3389/fonc.2020.563938openalex-snapshot

Dual-Target Peptide-Modified Erythrocyte Membrane-Enveloped PLGA Nanoparticles for the Treatment of Glioma

inferred← citeshttps://doi.org/10.3389/fphys.2023.1308632openalex-snapshot

Drug transport by red blood cells

inferred← citeshttps://doi.org/10.3389/fphys.2024.1399154openalex-snapshot

Mechanism of hypoxia-induced damage to the mechanical property in human erythrocytes—band 3 phosphorylation and sulfhydryl oxidation of membrane proteins

inferred← citeshttps://doi.org/10.3390/ijms22105264openalex-snapshot

Nucleic Acid Delivery with Red-Blood-Cell-Based Carriers

inferred← citeshttps://doi.org/10.3390/ijms24010475openalex-snapshot

Half-Life Extension and Biodistribution Modulation of Biotherapeutics via Red Blood Cell Hitch-Hiking with Novel Anti-Band 3 Single-Domain Antibodies

inferred← citeshttps://doi.org/10.3390/molecules28031013openalex-snapshot

The Effect of Selected Flavonoids and Lipoic Acid on Natural and Model Cell Membranes: Langmuir and Microelectrophoretic Methods

inferred← citeshttps://doi.org/10.3390/pharmaceutics12100999openalex-snapshot

Injectables and Depots to Prolong Drug Action of Proteins and Peptides

inferred← citeshttps://doi.org/10.3390/pharmaceutics13122045openalex-snapshot

Polymeric Nanoparticles Properties and Brain Delivery

inferred← citeshttps://doi.org/10.3390/pharmaceutics15020365openalex-snapshot

Extracellular Vesicles as New Players in Drug Delivery: A Focus on Red Blood Cells-Derived EVs

inferred← citeshttps://doi.org/10.51227/ojafr.2024.8openalex-snapshot

Processing of slaughterhouse blood for antianemic food products

Editorial review for independent work. ICSAC — the Institute for Complexity Science and Advanced Computing — runs a structured editorial panel for researchers publishing outside journals, and publishes on CiteStamp rails. Submission is free and goes through ORCID: icsacinstitute.org/submit.